State of Alaska, Department of Revenue
Position in LENZ — LENZ Therapeutics, Inc.
CIK 1370102
JUNEAU, AK
Position in LENZ
as of Mar 31, 2026
· filed Apr 20, 2026
Position Value
$221,054
-$85,490 QoQ
Shares Held
24,159
+26.1% QoQ
Ownership
0.077%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in LENZ Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026State of Alaska, Department of Revenue holds $92,461,767 across 47 Biotechnology names. LENZ ranks #34 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
33,180 | $14,816,196 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
18,363 | $14,187,988 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
157,004 | $10,147,168 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
42,042 | $7,948,040 | |
| 5 | KRYS |
Krystal Biotech, Inc.
|
17,484 | $4,516,465 | |
| 6 | PTGX |
Protagonist Therapeutics, Inc
|
37,147 | $3,915,293 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
44,098 | $3,004,396 | |
| 8 | TGTX |
Tg Therapeutics, Inc.
|
86,343 | $2,868,314 |
All Filings in LENZ
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $221,054 | 24,159 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $306,544 | 19,159 | Shares | Sole | 2026-01-23 | |
| No filing history on record for this holder in this stock. | ||||||